Nav: Home

Rigorous study finds widely used treatment for infection fails young cancer patients

June 05, 2018

(MEMPHIS, Tenn. - JUNE 5, 2018) A treatment designed to reduce bloodstream infections due to central venous catheters that had worked well in lab studies and is commonly used around the world, but had not been rigorously tested, failed to protect young cancer patients from recurring or new infections and left them at higher risk for complications. St. Jude Children's Research Hospital investigators led the study, which appears online today in the journal The Lancet Infectious Diseases.

The study focused on the effectiveness of ethanol-lock therapy for treatment and prevention of bloodstream infections and related complications in pediatric cancer patients with central venous catheters, known as central lines.

Central lines are surgically implanted and connected to the bloodstream, making it easier to draw blood and deliver chemotherapy, fluids and other treatments without repeated needle sticks. But about 25 percent of pediatric cancer patients develop central line-associated bloodstream infections that disrupt cancer treatment and sometimes result in hospitalization, long-term complications or death. Despite antibiotic therapy, one-third of patients develop persistent or multiple infections and even more patients undergo additional surgery to replace central lines.

"Ethanol-lock therapy works in the laboratory to kill even tough-to-eradicate bacterial communities called biofilm," said first and corresponding author Joshua Wolf, MBBS, an assistant member of the St. Jude Department of Infectious Diseases. "We knew anecdotally that ethanol-lock therapy is used at many hospitals in an effort to prevent new or recurring central line bloodstream infections in children with cancer."

But in a double-blind, randomized placebo-controlled clinical trial of children and young adults with cancer and blood disorders, Wolf and his colleagues found ethanol-lock therapy was no better than saline solution (placebo) at preventing new or repeat bloodstream infections. It was also no better than placebo at reducing central line replacement surgeries.

Worse, patients who received ethanol therapy were 2.5-times more likely than patients in the placebo group to develop catheter blockages that required treatment with blood thinners.

"Based on these results, ethanol-lock therapy should not be routinely used in children with cancer or hematologic disorders," Wolf said. "Serious bacterial infections remain a life-threatening problem that is the focus of intensive ongoing research."

The study included 94 patients being treated at St. Jude and in Australia at the Royal Children's Hospital, Melbourne. The patients were all receiving antibiotics for treatment of central line-associated bloodstream infections. The patients were randomly assigned to the same six-month schedule of central line treatment with either 70 percent ethanol solution or saline solution.

About 44 percent of patients in both groups developed new or recurring infections or required surgical replacement of central lines. In addition, 58 percent of patients in the ethanol group needed blood-thinners to open blocked central lines compared to about 33 percent in the placebo group.
-end-
The senior author is Patricia Flynn, M.D., of St. Jude. The other authors are Kim Allison, Li Tang, Julie Richardson, Kristen Branum, Jeffrey Rubnitz, Aditya Gaur, Hana Hakim, Yin Su, Sara Federico and Randall Hayden, all of St. Jude; Tom Connell, Eloise Borello, Francoise Mechinaud, Paul Monagle and Nigel Curtis, all of the Royal Children's Hospital; and Leon Worth of the Peter MacCallum Cancer Centre, Melbourne, Australia.

The research was funded in part by the Australian Government Research Training Scholarship and ALSAC, the fundraising and awareness arm of St. Jude.

St. Jude Children's Research Hospital

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.